Results of a Pilot Fourth year Medical Student Elective in Antimicrobial Stewardship
Background. Antimicrobial stewardship (AS) is not currently a formal part of the medical school curriculum. We hypothesized that presenting the topic to medical students can raise awareness of the effects of inappropriate antibiotic prescribing.
Methods. A fourth-year medical student elective was created that included microbiological, clinical, and multidisciplinary elements. Week 1: Understand mechanisms of bacterial resistance and clinical implications. Week 2: Rotate on Infectious Disease (ID) Consult Service. Complete Wake Forest and CDC online study modules. Michigan Medicine faculty recently created new AS modules; these were reviewed and feedback was provided. Week 3: Meet with ID pharmacists and attend AS and Patient Safety Effectiveness Program meetings. Review the process behind creating AS guidelines and antibiograms. Week 4: Give a presentation to the third-year medical students at University of Michigan Medical School. Have the class complete pre-and post-surveys (before and after the presentation, respectively) of nine questions regarding important topics in AS.
Results. The presentation created featured an innovative antibiotic-antimicrobial dating application model that was used to teach important AS scenarios. 96 third-year medical students completed the pre-survey and 62/96 completed the post-survey. The average correct response for multiple-choice questions on the pre-survey was 3.34/8 (42%) and 5.18/8 (65%) on the post-survey. Twenty-one/96 (22%) who took the pre-survey responded that they did not know what AS is, compared with 1/62 (1.6%) in the post-survey.
Conclusion.
Having an interdisciplinary clerkship for medical students to explore and learn about AS could have large impact, though sustainability is unknown. In this cohort, a focused social media savvy review helped medical students learn basic elements of AS, demonstrated by the improvement in student scores on the subsequent surveys. As patient and staff education becomes a requirement of AS programs, medical student education should be incorporated as well.
Disclosures. All authors: No reported disclosures. Background. Antimicrobial stewardship is critical to optimizing the treatment of infections and reducing the adverse events associated with antimicrobial use including Clostridium difficile infection. National public health and quality organizations have identified a number of core elements of successful hospital antimicrobial stewardship programs, including leadership commitment and education. This study was conducted at a 350-bed community teaching hospital with an established antimicrobial stewardship program. The purpose of this study was to identify the impact of leadership commitment and education on antimicrobial use and hospital-acquired Clostridium difficile at a community hospital.
Effect of Leadership Commitment and Education on Antimicrobial Use and Hospital-Acquired Clostridium difficile infection rates at a Community Hospital
Methods. This was a pre-and post-intervention cohort study. Hospital leadership demonstrated commitment to antimicrobial stewardship through the addition of the Vice President of the Department of Medicine as well as additional clinical pharmacy support to the Antimicrobial Stewardship team. Education was provided to staff in the form of competencies for physicians, pharmacists and nurses, as well as didactic lectures and resources available on the internal antimicrobial stewardship website. Data were collected for one-year pre-and post-intervention periods, calendar year 2015 and 2016, respectively. Antimicrobial use was measured as defined daily doses (DDDs) per 1000 patient-days.
Results. Compliance with antimicrobial stewardship competencies was 14% (107/759) for physicians, 74% (26/35) for pharmacists and 89% (588/658) for nurses. Antimicrobial use in the post-intervention period was 518.14 DDDs per 1000 patientdays compared with 558.99 DDDs per 1000 patient-days in the pre-intervention period. This was a decrease of 7.3% (CI 6.15-8.44, P < 0.001). The hospital-acquired Clostridium difficile infection rate decreased from 5.22 cases per 10,000 patient-days in the pre-intervention period to 3.81 cases per 10,000 patient-days in the post-intervention period, a decrease of 27% (CI -19.4-55.6, P = 0.21).
Conclusion. Antimicrobial stewardship program expansion in the areas of leadership commitment and education was associated with a 7% decrease in antibiotic use. This was associated with a non-statistically significant decrease in the rate of hospital-acquired Clostridium difficile infection.
Disclosures. All authors: No reported disclosures. October 5, 2017: 12:30 PM Background. The antimicrobial formulary is a key tool in antimicrobial stewardship (ASP). Agents added to formulary typically are those that have been formally reviewed and determined to have a place in therapy in a given facility. Non-formulary (NF) agents generally are those that have not been requested, or were deemed not optimal based on spectrum, formulation, or cost. We evaluated NF antimicrobial orders to identify possible gaps in optimal use and process.
Formulary Management and Antimicrobial
Methods. IRB-exempt ecological evaluation of NF antimicrobial use in multi-site healthcare system. Anonymous data collected: NF antimicrobial agents ordered between 2010-2017. Drug use characteristics: class, duration, availability of formulary alternatives, and time since FDA approval. Descriptive statistics were used to characterize NF use. Additional formulary processes evaluated: requests, reviews, and decisions.
Results. 2041 NF antimicrobial were ordered for 44 different agents, representing < 0.01% of all medication orders. Drug class: Antibacterials (65%), antivirals (21%), antifungals (12%). Most common agents: levofloxacin (25%), cefpodoxime (17%), anidulafungin (10%), nitrofurantoin macrocrystal (10%), ledipasvir-sofosbuvir (6%). Of 421 orders for antivirals, indication was: 53% for hepatitis C. Thirty-seven percent of orders were for 1 day only, suggesting continued use outpatient. 3% of orders had an extended duration of therapy > 14 days. 185 orders were placed for new drugs (within 12 months of FDA-approval), 73% were for HIV agents. 11 of 44 NF agents were subsequently added to the formulary. During the study period, 17 antimicrobial were requested for either inpatient or outpatient formulary addition; all were approved with use criteria or infectious diseases restriction. Of 16 antimicrobial agents FDA-approved during the study period, 6 were requested and added to the inpatient
